Kidney transplantation in an adult with transfusion-dependent beta thalassemia: A challenging case report and literature review

Tsampika-Vasileia N Kalamara, Evangelia G Zarkada, Efstratios D Kasimatis, Athanasios G Kofinas, Philippos I Klonizakis, Efthymia C Vlachaki


The markedly increased survival of transfusion-dependent beta thalassemia patients has led to the recognition of new complications, such as renal disorders. Kidney transplantation is nowadays the preferred treatment option for end-stage kidney disease (ESKD). We describe a case of a 49-year-old woman with β-Transfusion Dependent Thalassemia, who developed ESKD as a result of focal segmental glomerulosclerosis and received a deceased-donor kidney transplant following hemodialysis for over a decade. The particular challenges of this case are discussed, including the long-term survival in hemodialysis. Our patient had to overcome multiple obstacles, including hypercoagulability issues presented in the form of thromboembolism, infections, such as hepatitis C and gastroenteritis, and the acute T-cell–mediated rejection, which had to be managed postoperatively. A review of the current literature revealed only one previous report of a thalassemia patient who successfully underwent renal transplantation. More than a year after the transplantation our patient presents with a normal glomerular filtration rate (GFR=62ml/min/1.73m2) and creatinine level (Cr=0.96mg/dL) and is transfused every 3 weeks. In conclusion, renal transplantation is possible in patients with TDT and should not be discouraged. Regular transfusions and optimal follow-up for the elimination of post-transplant complications are required.


renal transplantation, thalassemia, glomerulosclerosis, hemodialysis, case report

Full Text:



Olivieri NF. The beta-thalassemias. N Engl J Med. 1999;341(2):99-109. doi: 10.1056/NEJM199907083410207. Erratum in: N Engl J Med 1999;341(18):1407. PMID: 10395635.

Cooley TB, Lee P. A series of cases of splenomegaly in children and peculiar changes in bones; report of cases. Am J Dis Child. 1927; 34: 347–363.

Martin A, Thompson AA. Thalassemias. Pediatr Clin North Am. 2013;60(6):1383-1391. doi: 10.1016/j.pcl.2013.08.008. PMID: 24237977.

Taher AT, Weatherall DJ, Cappellini MD. Thalassaemia. Lancet. 2018;391(10116):155-167. doi: 10.1016/S0140-6736(17)31822-6. PMID: 28774421.

Origa R. β-Thalassemia. Genet Med. 2017;19(6):609-619. doi: 10.1038/gim.2016.173. PMID: 27811859.

Taher AT, Cappellini MD. How I manage medical complications of β-thalassemia in adults. Blood. 2018;132(17):1781-1791. doi: 10.1182/blood-2018-06-818187. PMID: 30206117.

Tsai JL, Tsai SF. Recovery of Renal Function in a Kidney Transplant Patient After Receiving Hemodialysis for 4 Months. Exp Clin Transplant. 2020;18(1):112-115. doi: 10.6002/ect.2017.0323. PMID: 30066627.

Emam M, Moneem MA, Gheith O, et al. Successful kidney transplantation of a patient with thalassemia major: case report and review of literature. J Egypt Soc Nephrol Transplant. 2021;21:144-147.

Quinn CT, Johnson VL, Kim HY, et al. Renal dysfunction in patients with thalassaemia. Br J Haematol. 2011;153(1):111-117. doi: 10.1111/j.1365-2141.2010.08477.x. PMID: 21332704; PMCID: PMC4250090.

Demosthenous C, Vlachaki E, Apostolou C, et al. Beta-thalassemia: renal complications and mechanisms: a narrative review. Hematology. 2019;24(1):426-438. doi: 10.1080/16078454.2019.1599096. PMID: 30947625.

Kriz W, Lemley KV. A potential role for mechanical forces in the detachment of podocytes and the progression of CKD. J Am Soc Nephrol. 2015;26(2):258-269. doi: 10.1681/ASN.2014030278. PMID: 25060060; PMCID: PMC4310663.

Haddad A, Tyan P, Radwan A, Mallat N, Taher A. β-Thalassemia Intermedia: A Bird's-Eye View. Turk J Haematol. 2014;31(1):5-16. doi: 10.4274/Tjh.2014.0032. PMID: 24764724; PMCID: PMC3996637.

Burton H, Iyamu Perisanidou L, Steenkamp R, et al. Causes of renal allograft failure in the UK: trends in UK Renal Registry and National Health Service Blood and Transplant data from 2000 to 2013. Nephrol Dial Transplant. 2019;34(2):355-364. doi: 10.1093/ndt/gfy168. PMID: 29982787.

Papalois V, Mossialos E. Report for a new national solid organ donation and transplantation plan in Greece. London School of Economics and Political Science. London, UK. 2021. [ available at 6/18/2023]

Kramer A, Boenink R, Stel VS, et al. The ERA-EDTA Registry Annual Report 2018: a summary. Clin Kidney J. 2020;14(1):107-123. doi: 10.1093/ckj/sfaa271. PMID: 33564410; PMCID: PMC7857839.

Scornik JC, Meier-Kriesche HU. Blood transfusions in organ transplant patients: mechanisms of sensitization and implications for prevention. Am J Transplant. 2011;11(9):1785-1791. doi: 10.1111/j.1600-6143.2011.03705.x. PMID: 21883910.

Taher AT, Otrock ZK, Uthman I, Cappellini MD. Thalassemia and hypercoagulability. Blood Rev. 2008;22(5):283-292. doi: 10.1016/j.blre.2008.04.001. PMID: 18511163.

Roumeliotis S, Dounousi E, Salmas M, Eleftheriadis T, Liakopoulos V. Vascular Calcification in Chronic Kidney Disease: The Role of Vitamin K- Dependent Matrix Gla Protein. Front Med (Lausanne). 2020;7:154. doi: 10.3389/fmed.2020.00154. PMID: 32391368; PMCID: PMC7193028.

Goodkin DA, Bieber B, Jadoul M, et al. Mortality, Hospitalization, and Quality of Life among Patients with Hepatitis C Infection on Hemodialysis. Clin J Am Soc Nephrol. 2017;12(2):287-297. doi: 10.2215/CJN.07940716. PMID: 27908905; PMCID: PMC5293341.

Aziz F, Parajuli S, Garg N, et al. How Should Acute T-cell Mediated Rejection of Kidney Transplants Be Treated: Importance of Follow-up Biopsy. Transplant Direct. 2022;8(4):e1305. doi: 10.1097/TXD.0000000000001305. PMID: 35372674; PMCID: PMC8963842.

Chemouny JM, Suberbielle C, Rabant M, et al. De Novo Donor-Specific Human Leukocyte Antigen Antibodies in Nonsensitized Kidney Transplant Recipients After T Cell-Mediated Rejection. Transplantation. 2015;99(5):965-972. doi: 10.1097/TP.0000000000000448. PMID: 25340597.

Chapman JR. The KDIGO Clinical Practice Guidelines for the Care of Kidney Transplant Recipients. Transplantation. 2010;89(6):644-645. doi: 10.1097/TP.0b013e3181d62f1b

Dighriri IM, Alrabghi KK, Sulaiman DM, et al. Efficacy and Safety of Luspatercept in the Treatment of β-Thalassemia: A Systematic Review. Cureus. 2022;14(11):e31570. doi: 10.7759/cureus.31570. PMID: 36540460; PMCID: PMC9756914.


Copyright (c) 2023 Tsampika-Vasileia N Kalamara, Evangelia G Zarkada, Efstratios D Kasimatis, Athanasios G Kofinas, Philippos I Klonizakis, Efthymia C Vlachaki

Creative Commons License
Archive of Clinical Cases is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.


ISSN: 2360-6975